Viridian Therapeutics, Inc.\DE (VRDN) Depreciation & Amortization (CF) (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) recorded Depreciation & Amortization (CF) of $117,000 in Q2 2026, up 3.5% from $113,000 a year earlier but down 3.3% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends
On a TTM basis, Viridian Therapeutics, Inc.\DE's Depreciation & Amortization (CF) came in at $508,000 as of Jun 30, 2026, up 5.2% year-over-year; for FY2025, it came in at $500,000, down 7.4% from FY2024.
- Annual Depreciation & Amortization (CF) has a five-year compound annual growth rate of 15.9% (FY2020 to FY2025).
- Across earlier years, Depreciation & Amortization (CF) came in at $540,000 in FY2024 (+3.4%), $522,000 in FY2023 (+74.0%), $300,000 in FY2022 (+150.0%) and $120,000 in FY2021 (-49.8%).
- Quarterly Depreciation & Amortization (CF) has ranged from $30,000 in Q3 2021 to $160,000 in Q4 2025 over the past five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has increased for three consecutive quarters, with an average decline of 5.0% over the last eight quarters.
- Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 340.6% in Q4 2022, against a decline of 47.4% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $121,000 (Q1 2026), $160,000 (Q4 2025) and $110,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.20 Bn | 2.20 Bn | - | 117,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Jun 30, 2025 | 113,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Dec 31, 2024 | 123,000.00 |
| Sep 30, 2024 | 130,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 145,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Sep 30, 2023 | 135,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 62,000.00 |
| Jun 30, 2022 | 57,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 30,000.00 |
API Access
Viridian Therapeutics, Inc.\DE Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();